Early research (Phase 1)Study completedNCT01855945
What this trial is testing
Safety and Immunogenicity of Three Dosage Levels of Swine Influenza Vaccine in Children Ages 3 to <9 Years, Adolescents 9 to <18 Years, Adults 18 to <65 Years and Elderly 65 Years and Older.
Who this might be right for
Prophylaxis of A/H3N2v Influenza
Novartis Vaccines 627